Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Filing Meeting, February 8, 2012 pm - Octaplas


From:                    Wyatt, Michael (Keith)
Sent:                      Wednesday, February 08, 2012 12:18 PM
To:                         Rana, Pratibha
Cc:                         Kirschbaum, Nancy; Mahmood, Iftekhar
Subject:                 Filing Meeting/STN 125416/0/OctaplastLG/Pratibha
Dear Pratibha
Based on a cursory review of the Octaplas LG submission, STN 125416/0, I have not identified any pharm/tox issues that would prevent this BLA from being filed.
M. Keith Wyatt, Ph. D.
Food and Drug Administration
1401 Rockville Pike
Rockville, MD 20852-1448
(301) 827-9258
(301) 827-3534 (fax)

Page Last Updated: 05/19/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English